Bruker Corporation BKD.F Stock
Bruker Corporation Price Chart
Bruker Corporation BKD.F Financial and Trading Overview
Bruker Corporation stock price | 83.84 EUR |
Previous Close | 71 EUR |
Open | 69 EUR |
Bid | 69 EUR x 60000 |
Ask | 69.5 EUR x 60000 |
Day's Range | 69 - 69 EUR |
52 Week Range | 50.5 - 76 EUR |
Volume | 155 EUR |
Avg. Volume | 11 EUR |
Market Cap | 10.12B EUR |
Beta (5Y Monthly) | 1.159507 |
PE Ratio (TTM) | 35.9375 |
EPS (TTM) | 2.7 EUR |
Forward Dividend & Yield | 0.19 (0.26%) |
Ex-Dividend Date | May 31, 2023 |
1y Target Est | 84.36 EUR |
BKD.F Valuation Measures
Enterprise Value | 11.08B EUR |
Trailing P/E | 35.9375 |
Forward P/E | 30.941704 |
PEG Ratio (5 yr expected) | 2.61 |
Price/Sales (ttm) | 3.8627102 |
Price/Book (mrq) | 8.579955 |
Enterprise Value/Revenue | 4.226 |
Enterprise Value/EBITDA | 19.329 |
Trading Information
Bruker Corporation Stock Price History
Beta (5Y Monthly) | 1.159507 |
52-Week Change | 25.66% |
S&P500 52-Week Change | 20.43% |
52 Week High | 76 EUR |
52 Week Low | 50.5 EUR |
50-Day Moving Average | 70.45 EUR |
200-Day Moving Average | 64.51 EUR |
BKD.F Share Statistics
Avg. Volume (3 month) | 11 EUR |
Avg. Daily Volume (10-Days) | 1 EUR |
Shares Outstanding | 146.73M |
Float | 98.67M |
Short Ratio | N/A |
% Held by Insiders | 32.86% |
% Held by Institutions | 72.08% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.2 |
Trailing Annual Dividend Yield | 0.28% |
5 Year Average Dividend Yield | 33.00% |
Payout Ratio | 0.0952 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 11.88% |
Operating Margin (ttm) | 18.34% |
Gross Margin | 51.90% |
EBITDA Margin | 21.86% |
Management Effectiveness
Return on Assets (ttm) | 8.21% |
Return on Equity (ttm) | 27.90% |
Income Statement
Revenue (ttm) | 2.62B EUR |
Revenue Per Share (ttm) | 17.75 EUR |
Quarterly Revenue Growth (yoy) | 15.19% |
Gross Profit (ttm) | 1.31B EUR |
EBITDA | 573M EUR |
Net Income Avi to Common (ttm) | 311.5M EUR |
Diluted EPS (ttm) | 1.92 |
Quarterly Earnings Growth (yoy) | 24.19% |
Balance Sheet
Total Cash (mrq) | 613.4M EUR |
Total Cash Per Share (mrq) | 4.18 EUR |
Total Debt (mrq) | 1.24B EUR |
Total Debt/Equity (mrq) | 102.46 EUR |
Current Ratio (mrq) | 2.034 |
Book Value Per Share (mrq) | 8.042 |
Cash Flow Statement
Operating Cash Flow (ttm) | 284.1M EUR |
Levered Free Cash Flow (ttm) | 140.48M EUR |
Profile of Bruker Corporation
Country | Germany |
State | MA |
City | Billerica |
Address | 40 Manning Road |
ZIP | 01821 |
Phone | 978 663 3660 |
Website | https://www.bruker.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 8525 |
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
Q&A For Bruker Corporation Stock
What is a current BKD.F stock price?
Bruker Corporation BKD.F stock price today per share is 83.84 EUR.
How to purchase Bruker Corporation stock?
You can buy BKD.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bruker Corporation?
The stock symbol or ticker of Bruker Corporation is BKD.F.
Which industry does the Bruker Corporation company belong to?
The Bruker Corporation industry is Medical Devices.
How many shares does Bruker Corporation have in circulation?
The max supply of Bruker Corporation shares is 137.67M.
What is Bruker Corporation Price to Earnings Ratio (PE Ratio)?
Bruker Corporation PE Ratio is 31.05185000 now.
What was Bruker Corporation earnings per share over the trailing 12 months (TTM)?
Bruker Corporation EPS is 2.7 EUR over the trailing 12 months.
Which sector does the Bruker Corporation company belong to?
The Bruker Corporation sector is Healthcare.